Literature DB >> 29116594

Elevated expression of EBV and TLRs in the brain is associated with Rasmussen's encephalitis.

Xin Wang1, Yisong Wang1, Dong Liu2, Peigang Wang1, Dongying Fan1, Yuguang Guan2, Tianfu Li3, Guoming Luan4,5,6, Jing An7,8.   

Abstract

Rasmussen's encephalitis (RE) is a rare pediatric neurological disorder, the etiology of which remains unclear. It has been speculated that the immunopathogenesis of RE involves damage to neurons, which eventually leads to the occurrence of RE. Viral infection may be a critical factor in triggering RE immunopathogenesis. In this study, we analyzed the expression of Epstein-Barr virus (EBV) antigens as well as of Toll-like receptor 3 (TLR3), TLR9, and downstream adapter TIRdomain-containing adapter-inducing interferon-β (TRIF) in the brain tissues of 26 patients with RE and 16 control individuals using immunohistochemistry (IHC). In the RE group, EBV antigens were detected in 53% of individuals at various expression levels. In contrast, there was no detectable EBV antigen expression in control brain tissues. Moreover, we found marked increases in the expression of TLR3, TLR9, and TRIF in the brain tissues of RE patients compared with levels in the control group. Furthermore, among RE cases, EBV expression and high TLR3 expression were associated with more severe brain atrophy. Our results suggest that the elevated expression of EBV and TLRs may be involved in RE occurrence through the activation of downstream molecules.

Entities:  

Keywords:  Epstein-Barr virus (EBV); Rasmussen’s encephalitis (RE); TIR-domain-containing adapter-inducing interferon-β (TRIF); Toll-Like receptor (TLR); epilepsy

Mesh:

Substances:

Year:  2017        PMID: 29116594      PMCID: PMC6598921          DOI: 10.1007/s12250-017-4058-8

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  25 in total

1.  Broad expression of Toll-like receptors in the human central nervous system.

Authors:  Malika Bsibsi; Rivka Ravid; Djordje Gveric; Johannes M van Noort
Journal:  J Neuropathol Exp Neurol       Date:  2002-11       Impact factor: 3.685

2.  The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies.

Authors:  Carlos A Pardo; Eileen P G Vining; Liping Guo; Richard L Skolasky; Benjamin S Carson; John M Freeman
Journal:  Epilepsia       Date:  2004-05       Impact factor: 5.864

3.  Elevated expression of human papillomavirus antigen in brain tissue of patients with Rasmussen's encephalitis.

Authors:  Shuai Chen; Sichang Chen; Yuguang Guan; Yao Zhang; Xueling Qi; Jing An; Yisong Wang; Guoming Luan
Journal:  Epilepsy Res       Date:  2016-07-27       Impact factor: 3.045

4.  Surgical treatment of patients with Rasmussen encephalitis.

Authors:  Yuguang Guan; Jian Zhou; Guoming Luan; Xingzhou Liu
Journal:  Stereotact Funct Neurosurg       Date:  2014-02-06       Impact factor: 1.875

Review 5.  Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement.

Authors:  C G Bien; T Granata; C Antozzi; J H Cross; O Dulac; M Kurthen; H Lassmann; R Mantegazza; J-G Villemure; R Spreafico; C E Elger
Journal:  Brain       Date:  2005-02-02       Impact factor: 13.501

Review 6.  Rasmussen's encephalitis: a role for autoimmune cytotoxic T lymphocytes.

Authors:  Jan Bauer; Christian G Bien; Hans Lassmann
Journal:  Curr Opin Neurol       Date:  2002-04       Impact factor: 5.710

7.  Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis.

Authors:  Christian G Bien; Jan Bauer; Thomas L Deckwerth; Heinz Wiendl; Martina Deckert; Otmar D Wiestler; Johannes Schramm; Christian E Elger; Hans Lassmann
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

8.  Cytomegalovirus and Rasmussen's encephalitis.

Authors:  C Power; S D Poland; W T Blume; J P Girvin; G P Rice
Journal:  Lancet       Date:  1990-11-24       Impact factor: 79.321

9.  Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer.

Authors:  Liwei Wang; Daoyan Wei; Suyun Huang; Zhihai Peng; Xiangdong Le; Tsung Teh Wu; James Yao; Jaffer Ajani; Keping Xie
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

10.  Expression of human cytomegalovirus components in the brain tissues of patients with Rasmussen's encephalitis.

Authors:  Yao Zhang; Yisong Wang; Sichang Chen; Shuai Chen; Yuguang Guan; Changqing Liu; Tianfu Li; Guoming Luan; Jing An
Journal:  Virol Sin       Date:  2017-03-02       Impact factor: 4.327

View more
  4 in total

1.  Herpesviruses: epidemiology, pathogenesis, and interventions.

Authors:  Ke Lan; Min-Hua Luo
Journal:  Virol Sin       Date:  2017-10       Impact factor: 4.327

2.  Detection of EBV and HHV6 in the Brain Tissue of Patients with Rasmussen's Encephalitis.

Authors:  Dong Liu; Xin Wang; Yisong Wang; Peigang Wang; Dongying Fan; Sichang Chen; Yuguang Guan; Tianfu Li; Jing An; Guoming Luan
Journal:  Virol Sin       Date:  2018-10-29       Impact factor: 4.327

3.  Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome.

Authors:  A Orsini; G Costagliola; D Perna; M G Esposito; L Bonfiglio; P Striano; D Peroni; R Consolini; A Bonuccelli
Journal:  Epilepsy Behav Rep       Date:  2019-10-21

4.  Rasmussen's encephalitis is characterized by relatively lower production of IFN-β and activated cytotoxic T cell upon herpes viruses infection.

Authors:  Yi-Song Wang; Dong Liu; Xin Wang; Qiao-Li Luo; Ling Ding; Dong-Ying Fan; Qi-Liang Cai; Chong-Yang Tang; Wei Yang; Yu-Guang Guan; Tian-Fu Li; Pei-Gang Wang; Guo-Ming Luan; Jing An
Journal:  J Neuroinflammation       Date:  2022-03-26       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.